CCO Slideset

A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer

Source: A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer

A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer

Program Director: Gregory R. Mundy, MD

Faculty:

Michael Gnant, MD
Allan Lipton, MD

CREDIT INFORMATION

Release Date: February 12, 2010

Expiration Date: February 11, 2011

Physicians: maximum of 1.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe key signaling pathways driving the process of bone metastasis
Cite new findings on the use of bisphosphonates for the prevention of cancer treatment–induced bone loss
Summarize data on the safety and efficacy of osteoclast inhibitors in treating patients with bone metastases

Topics covered include:

Biology of Bone Metastasis
The Use of Bisphosphonates
Cancer Treatment-Induced Bone Loss
Targeting Osteoclast Inhibition

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.